User profiles for E. Koenig

Evan Koenig

Senior Vice President, Federal Reserve Bank of Dallas
Verified email at dal.frb.org
Cited by 1514

Protein synthesis in axons and terminals: significance for maintenance, plasticity and regulation of phenotype: with a critique of slow transport theory

J Alvarez, A Giuditta, E Koenig - Progress in neurobiology, 2000 - Elsevier
This article focuses on local protein synthesis as a basis for maintaining axoplasmic mass,
and expression of plasticity in axons and terminals. Recent evidence of discrete ribosomal …

Axonal and presynaptic protein synthesis: new insights into the biology of the neuron

…, BB Kaplan, J van Minnen, J Alvarez, E Koenig - Trends in …, 2002 - cell.com
… ,f (lower panels); emission maximum: 509 nm] show that ribosomal plaque domains are
unaffected after incubation with buffer alone (e, lower panel), but are eliminated after incubation …

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two …

…, D Podzamczer, JM Molina, S Oka, E Koenig… - The Lancet, 2015 - thelancet.com
E/C/F/tenofovir alafenamide or E/C/F/tenofovir disoproxil fumarate had virological success.
Renal and bone effects were significantly reduced in patients given E/… data suggest that E/C/F/…

Effects of locomotion training with assistance of a robot-driven gait orthosis in hemiparetic patients after stroke: a randomized controlled pilot study

B Husemann, F Muller, C Krewer, S Heller, E Koenig - Stroke, 2007 - Am Heart Assoc
Background and Purpose— The success of gait rehabilitation after stroke depends on active
walking exercises. However, the disabling after-effects of stroke often make such exercises …

Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study

K Scheidtmann, W Fries, F Müller, E Koenig - The Lancet, 2001 - thelancet.com
… Eberhard KoenigE Koenig was medical superintendent of the hospital and allowed us
to do our study there. He was also involved in preparation of both the study and the report. …

[PDF][PDF] The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

…, A Fitzek, A Gerhartl, A Brachner, N Geiger, EM König… - Stem cell reports, 2022 - cell.com
… S2B), BCEC-specific marker expression (Figure S2C), an intact tight-junction (TJ) network
(Figure S2D), transendothelial electrical resistance (TEER) values >1,000 U$cm2 (Figure S2E)…

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

…, B Bryant, F Zhan, WJ Chng, S Roels, E Koenig… - Blood, 2007 - ashpublications.org
The aims of this study were to assess the feasibility of prospective pharmacogenomics
research in multicenter international clinical trials of bortezomib in multiple myeloma and to …

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised …

…, G DiPerri, J Van Lunzen, E Koenig… - The Lancet Infectious …, 2016 - thelancet.com
Background Antiretroviral regimens containing tenofovir disoproxil fumarate have been
associated with renal toxicity and reduced bone mineral density. Tenofovir alafenamide is a …

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 …

PE Sax, A Pozniak, ML Montes, E Koenig, E DeJesus… - The Lancet, 2017 - thelancet.com
Background Integrase strand transfer inhibitors (INSTIs) coadministered with two
nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs) are recommended as first-line …

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma

…, L Dang, LR Dick, JJ Garnsey, E Koenig… - Blood, The Journal …, 2010 - ashpublications.org
MLN4924 is a potent and selective small molecule NEDD8-activating enzyme (NAE)
inhibitor. In most cancer cells tested, inhibition of NAE leads to induction of DNA rereplication, …